» Articles » PMID: 24882967

Effect of Emollients Containing Vegetable-derived Lactobacillus in the Treatment of Atopic Dermatitis Symptoms: Split-body Clinical Trial

Overview
Journal Ann Dermatol
Specialty Dermatology
Date 2014 Jun 3
PMID 24882967
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Atopic dermatitis (AD) patients suffer from xerosis. Proper skin care, including the use of emollients, may help improve xerosis and minimize disease exacerbation. Lactobacillus sakei probio 65, isolated from the Korean vegetable-based product kimchi, can decrease interleukin 4 and immunoglobulin E levels and inhibit Staphylococcus aureus. Moreover, it has reportedly shown positive dermatological effects in both animal and clinical studies.

Objective: To compare the effects of an emollient that contains Lactobacillus (treated) with a normal emollient (control) on AD.

Methods: This double-blind, randomized, split-body clinical trial involved 28 patients with AD. The patients applied the Lactobacillus-containing emollient on one side of their body and the control emollient on the other side twice daily for 4 weeks. Trans-epidermal water loss (TEWL) and skin capacitance were evaluated and investigator global assessment and the visual analogue scale (VAS) were administered on weeks 0, 1, 2, and 4.

Results: The treated sides had significantly lower TEWL and VAS values and significantly higher skin capacitance values over time than the control sides.

Conclusion: Topical application of Lactobacillus-containing emollients may improve the skin permeability of patients with AD.

Citing Articles

Global Trends and Scientific Impact of Topical Probiotics in Dermatological Treatment and Skincare.

Alves A, Martins Jr S, Belo J, Lemos M, de Matos Chaves Lima C, Silva C Microorganisms. 2024; 12(10).

PMID: 39458319 PMC: 11510400. DOI: 10.3390/microorganisms12102010.


Dermatological Health in the Light of Skin Microbiome Evolution.

Haykal D, Cartier H, Dreno B J Cosmet Dermatol. 2024; 23(12):3836-3846.

PMID: 39248208 PMC: 11626341. DOI: 10.1111/jocd.16557.


Innovative Approaches for Maintaining and Enhancing Skin Health and Managing Skin Diseases through Microbiome-Targeted Strategies.

Al-Smadi K, Leite-Silva V, Filho N, Lopes P, Mohammed Y Antibiotics (Basel). 2023; 12(12).

PMID: 38136732 PMC: 10741029. DOI: 10.3390/antibiotics12121698.


The vulvar microbiome in lichen sclerosus and high-grade intraepithelial lesions.

Pagan L, Huisman B, van der Wurff M, Naafs R, Schuren F, Sanders I Front Microbiol. 2023; 14:1264768.

PMID: 38094635 PMC: 10716477. DOI: 10.3389/fmicb.2023.1264768.


The Role of Probiotics in Skin Health and Related Gut-Skin Axis: A Review.

Gao T, Wang X, Li Y, Ren F Nutrients. 2023; 15(14).

PMID: 37513540 PMC: 10385652. DOI: 10.3390/nu15143123.


References
1.
Peral M, Martinez M, Valdez J . Bacteriotherapy with Lactobacillus plantarum in burns. Int Wound J. 2009; 6(1):73-81. PMC: 7951207. DOI: 10.1111/j.1742-481X.2008.00577.x. View

2.
Hoarau C, Lagaraine C, Martin L, Velge-Roussel F, Lebranchu Y . Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. J Allergy Clin Immunol. 2006; 117(3):696-702. DOI: 10.1016/j.jaci.2005.10.043. View

3.
Isolauri E, Majamaa H, Arvola T, Rantala I, Virtanen E, Arvilommi H . Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology. 1993; 105(6):1643-50. DOI: 10.1016/0016-5085(93)91059-q. View

4.
Leung D, Bieber T . Atopic dermatitis. Lancet. 2003; 361(9352):151-60. DOI: 10.1016/S0140-6736(03)12193-9. View

5.
Lucky A, Leach A, Laskarzewski P, Wenck H . Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol. 1997; 14(4):321-4. DOI: 10.1111/j.1525-1470.1997.tb00968.x. View